Neuropathologists specialize in diagnosing neurological diseases by examining tissue samples from the brain, spinal cord, and peripheral nervous system. Their work is essential in identifying the pathological causes of a wide array of neurological conditions, including tumors, neurodegenerative disorders, infections, and autoimmune diseases. By applying techniques like immunohistochemistry, electron microscopy, and genetic analysis, neuropathologists can identify abnormal tissue changes at the cellular and molecular levels, offering crucial insights for accurate diagnosis. Their expertise is vital for distinguishing between similar diseases, such as differentiating Alzheimer’s from other dementias or identifying primary brain tumors as opposed to metastatic lesions. Neuropathologists collaborate with a wide range of healthcare providers, including neurologists, neurosurgeons, and oncologists, to guide patient management and treatment decisions. Their research helps in the discovery of new biomarkers, deepens understanding of disease mechanisms, and informs the development of new therapeutic strategies for neurological conditions. In addition, neuropathologists are increasingly integrating digital pathology and AI-based technologies to improve diagnostic accuracy and efficiency. Their contribution extends beyond the clinical setting, playing a key role in forensic medicine by providing crucial insights into the causes of death in cases related to neurological diseases. Through their work, neuropathologists continue to push the boundaries of brain disease research, aiding in the advancement of treatments and improving patient outcomes.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States